Global PCR and NGS-Based Molecular Diagnostics Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Biomarker Discovery
  • 1.4.3 Blood Sample Testig
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Academics/Research Institutions
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 PCR and NGS-Based Molecular Diagnostics Market Perspective (2015-2026)
• 2.2 PCR and NGS-Based Molecular Diagnostics Growth Trends by Regions
  • 2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 PCR and NGS-Based Molecular Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key PCR and NGS-Based Molecular Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Market Size
  • 3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
  • 3.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2019
• 3.3 PCR and NGS-Based Molecular Diagnostics Key Players Head office and Area Served
• 3.4 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
• 3.5 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2021-2026)

5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application (2015-2026)

• 5.1 Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)
• 5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 6.2 PCR and NGS-Based Molecular Diagnostics Key Players in North America (2019-2020)
• 6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 7.2 PCR and NGS-Based Molecular Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 8.2 PCR and NGS-Based Molecular Diagnostics Key Players in China (2019-2020)
• 8.3 China PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 8.4 China PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 9.2 PCR and NGS-Based Molecular Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 10.2 PCR and NGS-Based Molecular Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 11.2 PCR and NGS-Based Molecular Diagnostics Key Players in India (2019-2020)
• 11.3 India PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 11.4 India PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America PCR and NGS-Based Molecular Diagnostics Market Size (2015-2020)
• 12.2 PCR and NGS-Based Molecular Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Thermofisher
  • 13.1.1 Thermofisher Company Details
  • 13.1.2 Thermofisher Business Overview and Its Total Revenue
  • 13.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020))
  • 13.1.5 Thermofisher Recent Development
• 13.2 Illumine
  • 13.2.1 Illumine Company Details
  • 13.2.2 Illumine Business Overview and Its Total Revenue
  • 13.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.2.5 Illumine Recent Development
• 13.3 Paragon Genomics
  • 13.3.1 Paragon Genomics Company Details
  • 13.3.2 Paragon Genomics Business Overview and Its Total Revenue
  • 13.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.3.5 Paragon Genomics Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview and Its Total Revenue
  • 13.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 Qiagen
  • 13.5.1 Qiagen Company Details
  • 13.5.2 Qiagen Business Overview and Its Total Revenue
  • 13.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.5.5 Qiagen Recent Development
• 13.6 Bioo Scientific
  • 13.6.1 Bioo Scientific Company Details
  • 13.6.2 Bioo Scientific Business Overview and Its Total Revenue
  • 13.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.6.5 Bioo Scientific Recent Development
• 13.7 Agilent
  • 13.7.1 Agilent Company Details
  • 13.7.2 Agilent Business Overview and Its Total Revenue
  • 13.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.7.5 Agilent Recent Development
• 13.8 Pillar Biosciences
  • 13.8.1 Pillar Biosciences Company Details
  • 13.8.2 Pillar Biosciences Business Overview and Its Total Revenue
  • 13.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.8.5 Pillar Biosciences Recent Development
• 13.9 LC-Bio Technologies (Hangzhou) CO. LTD.
  • 13.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
  • 13.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview and Its Total Revenue
  • 13.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
• 13.10 iGen Technologies
  • 13.10.1 iGen Technologies Company Details
  • 13.10.2 iGen Technologies Business Overview and Its Total Revenue
  • 13.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
  • 13.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 13.10.5 iGen Technologies Recent Development
• 13.11 Burning Rock
  • 10.11.1 Burning Rock Company Details
  • 10.11.2 Burning Rock Business Overview and Its Total Revenue
  • 10.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
  • 10.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2015-2020)
  • 10.11.5 Burning Rock Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer